Clinical cure · patients with tinea cruris and tinea corporis
1 finding from 1 review
Adverse effects Reported by investigators 'and' or 'or' participants · patients with tinea cruris and tinea corporis
It is very uncertain whether azoles changes adverse effects Reported by investigators 'and' or 'or' participants compared with benzylamines (very low certainty).
1 finding from 1 review
Recurrence · patients with tinea cruris and tinea corporis
It is very uncertain whether azoles changes relapse or recurrence Evidence of clinical or mycological disease… compared with benzylamines (very low certainty).
1 finding from 1 review
Participant‐judged cure Not assessed · patients with tinea cruris and tinea corporis
1 finding from 1 review
Adverse effects Reported by investigators 'and' or 'or' participants · patients with tinea cruris and tinea corporis
It is very uncertain whether terbinafine 1% cream/gel changes adverse effects Reported by investigators 'and' or 'or' participants compared with placebo cream/gel (very low certainty).
1 finding from 1 review
Duration of treatment until clinical cure Not assessed · patients with tinea cruris and tinea corporis
1 finding from 1 review
Mycological cure · patients with tinea cruris and tinea corporis
1 finding from 1 review
Clinical cure · patients with tinea cruris and tinea corporis
1 finding from 1 review
Adverse effects Reported by investigators 'and' or 'or' participants · patients with tinea cruris and tinea corporis
It is very uncertain whether azoles changes adverse effects Reported by investigators 'and' or 'or' participants compared with placebo (very low certainty).
1 finding from 1 review
Relapse or recurrence Not assessed · patients with tinea cruris and tinea corporis
1 finding from 1 review
Participant‐judged cure Not assessed · patients with tinea cruris and tinea corporis
1 finding from 1 review
Duration of treatment until clinical cure Not assessed · patients with tinea cruris and tinea corporis
1 finding from 1 review
Recurrence · patients with tinea cruris and tinea corporis
1 finding from 1 review
Participant‐judged cure Judgement of treatment as 'good' or 'very good' · patients with tinea cruris and tinea corporis
Terbinafine 1% cream/gel may leads to higher participant‐judged cure Judgement of treatment as 'good' or 'very… compared with placebo cream/gel (low certainty).
1 finding from 1 review
Duration of treatment until clinical cure Not assessed · patients with tinea cruris and tinea corporis
1 finding from 1 review
Mycological cure · patients with tinea cruris and tinea corporis
Naftifine 1% cream once or twice daily may leads to higher mycological cure Negative KOH microscopy and culture. Treatment… compared with placebo cream once or twice daily (low certainty).
1 finding from 1 review
Clinical cure · patients with tinea cruris and tinea corporis
Naftifine 1% cream once or twice daily may leads to higher clinical cure Resolution of clinical signs and symptoms at least 2… compared with placebo cream once or twice daily (low certainty).
1 finding from 1 review
Adverse effects Reported by investigators 'and' or 'or' participants · patients with tinea cruris and tinea corporis
It is very uncertain whether naftifine 1% cream once or twice daily changes adverse effects Reported by investigators 'and' or 'or' participants compared with placebo cream once or twice daily (very low certainty).
1 finding from 1 review